Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PHAT is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
30 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
161 filers reported a long position in PHAT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $135.3M | 12.5M | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | $81M | 7.5M | Unchanged |
| BlackRock, Inc. | $49.1M | 4.5M | +11.4% |
| Invesco Ltd. | $43.7M | 4M | -6.8% |
| Carlyle Group Inc. | $37.9M | 3.5M | Unchanged |
| MILLENNIUM MANAGEMENT LLC | $36.6M | 3.4M | -16.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | $28.8M | 2.7M | +2.8% |
| GW&K Investment Management, LLC | $23.5M | 2.2M | +52.5% |
| FRANKLIN RESOURCES INC | $21.4M | 2M | +98.2% |
| NEA Management Company, LLC | $21.3M | 2M | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.